arrow
P

Patrizia Bonadonna

university of verona
H指数:38
被引数:4,276

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Utricaria, and Chronic Rhinosinusitis With Nasal Polyps

首个用于过敏领域的生物类似药:CT-P39(Omlyclo-Omalizumab-Igec)适用于哮喘、慢性自发性荨麻疹和伴有鼻息肉的慢性鼻窦炎

2026-04-250
PRE
The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways—An EAACI Position Paper

上气道炎症性疾病中嗅觉测试的未满足需求——EAACI立场文件

2026-02-020
PRE
A real-life multicenter experience for the post-pandemic management of hypersensitivity reactions to Covid-19 vaccines

真实世界多中心经验:后疫情时代对Covid-19疫苗超敏反应的管理

Vaccine
IF3.5
2025-07-080
PRE
Safety and efficacy of extended venom immunotherapy maintenance intervals in mastocytosis

肥大细胞增生症中延长变应原免疫疗法维持间隔的安全性与有效性

2025-06-060
PRE
Otitis Media With Effusion (OME) and Eustachian Tube Dysfunction: The Role of Allergy and Immunity-An EAACI Position Paper

分泌性中耳炎(OME)与咽鼓管功能障碍:过敏与免疫的作用——EAACI立场文件

2025-04-170
PREAI
Factors Affecting the Safety and Effectiveness of Venom Immunotherapy

影响蛇毒免疫疗法安全性和有效性的因素

2025-02-180
OA
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM
2024-12-012
OAAI
Obituary: Professor Marcus Maurer, Berlin, Germany
2024-09-280
PRE
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal
BONE
IF3.6
2024-09-011
PRE
Professor Peter Valentin Tomazic, Graz, Austria

Peter Valentin Tomazic教授,奥地利格拉茨

2024-06-250
PRE
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry
2024-04-234
PRE
EAACI/ENDA position paper on drug provocation testing

EAACI/ENDA关于药物挑衅测试的立场文件

2023-12-2820
OA
Resensitization in suspected penicillin allergy

疑似青霉素过敏的复敏

2022-09-1510
OA